Antihypertensive effects exerted by enalapril in mild to moderate hypertension are not associated with changes in the circulating levels of nitric oxide-related markers (2011)
- Authors:
- USP affiliated author: SANTOS, JOSE EDUARDO TANUS DOS - FMRP
- School: FMRP
- DOI: 10.1007/s00228-011-1003-x
- Subjects: FÁRMACOS (EFEITOS); ÓXIDO NÍTRICO; ESTRESSE OXIDATIVO; HIPERTENSÃO
- Language: Inglês
- Imprenta:
- Place of publication: Heidelberg
- Date published: 2011
- Source:
- Título do periódico: European Journal of Clinical Pharmacology
- ISSN: 0031-6970
- Volume/Número/Paginação/Ano: v. 67, n. 4, p. 365-370, 2011
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
SILVA, Pâmela Souza et al. Antihypertensive effects exerted by enalapril in mild to moderate hypertension are not associated with changes in the circulating levels of nitric oxide-related markers. European Journal of Clinical Pharmacology, v. 67, n. 4, p. 365-370, 2011Tradução . . Acesso em: 02 jul. 2022. -
APA
Silva, P. S., Tanus-Santos, J. E., Fontana, V., Palei, A. C. T., Sertorio, J. T. C., & Biagi, C. (2011). Antihypertensive effects exerted by enalapril in mild to moderate hypertension are not associated with changes in the circulating levels of nitric oxide-related markers. European Journal of Clinical Pharmacology, 67( 4), 365-370. doi:10.1007/s00228-011-1003-x -
NLM
Silva PS, Tanus-Santos JE, Fontana V, Palei ACT, Sertorio JTC, Biagi C. Antihypertensive effects exerted by enalapril in mild to moderate hypertension are not associated with changes in the circulating levels of nitric oxide-related markers. European Journal of Clinical Pharmacology. 2011 ; 67( 4): 365-370.[citado 2022 jul. 02 ] -
Vancouver
Silva PS, Tanus-Santos JE, Fontana V, Palei ACT, Sertorio JTC, Biagi C. Antihypertensive effects exerted by enalapril in mild to moderate hypertension are not associated with changes in the circulating levels of nitric oxide-related markers. European Journal of Clinical Pharmacology. 2011 ; 67( 4): 365-370.[citado 2022 jul. 02 ] - Atorvastatina reduz a hipertensão arterial pulmonar causada por embolia pulmonar aguda (EPA) em ratos
- Chronic antihypertensive effects of sodium nitrite in L-name-induced hypertension in rats
- eNos haplotype associated with hypertension in obese children and adolescents
- Pharmacogenetic relevance of endothelial nitric oxide synthase polymorphisms and gene interactions
- Lack of association between genetic polymorphism of FTO, AKT1 and AKTIP in childhood overweight and obesity
- Sodium nitrite does not inhibit circulating angiotensin converting enzyme activity
- Matrix metalloproteinase-9 genetic variation affect MMP-9 levels in obese children
- Sildenafil improves the beneficial hemodynamic effects exerted by atorvastatin during acute pulmonary thromboembolism
- Matrix metalloproteinases as drug targets in preeclampsia
- Quercetin restores plasma nitrite and nitroso species levels in renovascular hypertension
Informações sobre o DOI: 10.1007/s00228-011-1003-x (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
